Human Genome Sciences (HGS) is a company with a drug discovery platform that has resulted in many late stage products which have attracted large partners. Its lead product is Benlysta, the first product approved for lupus in over 50 years which is partnered with GSK. Benlysta has blockbuster potential, has proven to be safe and effective in 2 large Phase III studies, and was launched in March 2011.

HGS has 2 other late stage products partnered with GSK for diabetes and cardiovascular disease.

Back